Alcoholic Hepatitis Epidemiology Forecast

DelveInsight’s ‘Alcoholic Hepatitis - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical, and forecasted Alcoholic Hepatitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017–2030


Alcoholic Hepatitis: Understanding

The DelveInsight’s Alcoholic Hepatitis epidemiology report gives a thorough understanding of Alcoholic Hepatitis by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Alcoholic Hepatitis in the US and Europe. Moreover, the report covers the Alcoholic Hepatitis scenario's detailed information in seven major countries (US, EU5, and Japan).


Epidemiology Perspective by DelveInsight

This section encompassing Alcoholic Hepatitis epidemiology provides insights about historical and current patient pool and forecasted trends for every seven major countries. The Alcoholic Hepatitis epidemiology data are studied through all possible divisions to better understand the disease scenario in 7MM. This segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports, and views of key opinion leaders.


Detailed Epidemiology Segmentation

The Alcoholic Hepatitis epidemiology covered in the report provides historical as well as forecasted Alcoholic Hepatitis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.


The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Report Highlights

  • 11-year Forecast of Alcoholic Hepatitis Epidemiology
  • 7MM Coverage
  • Total Prevalent cases of Alcoholic Hepatitis
  • Diagnosed Cases of Alcoholic Hepatitis
  • Severity-specific Cases of Alcoholic Hepatitis
  • Gender-specific Cases of Alcoholic Hepatitis


KOL Views

We interview KOLs and include SME’s opinion through primary research to fill the data gaps and validate our secondary research. The view helps understand the total patient population and current treatment pattern. It will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM concerning the patient population pertaining to Alcoholic Hepatitis?
  • What are the key findings pertaining to the Alcoholic Hepatitis epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2017–2030)?
  • What would be the total number of patients of Alcoholic Hepatitis across the 7MM during the forecast period (2017–2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017–2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017–2030)?
  • What are the disease risks, burdens, and unmet needs of Alcoholic Hepatitis?
  • What are the currently available treatments of Alcoholic Hepatitis?


Reasons to buy

The Alcoholic Hepatitis Epidemiology report will allow the user to:

  • Develop business strategies by understanding the trends shaping and driving the global Alcoholic Hepatitis market.
  • Quantify patient populations in the global Alcoholic Hepatitis market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Alcoholic Hepatitis therapeutics in each of the markets covered.
  • Understand the magnitude of the Alcoholic Hepatitis population by its epidemiology.
  • The Alcoholic Hepatitis Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over an 11-year forecast period using reputable sources.


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights

2. Executive Summary of Alcoholic Hepatitis

3. SWOT Analysis for Alcoholic Hepatitis

4. Alcoholic Hepatitis: Disease Overview

4.1. Introduction

4.2. Alcoholic Liver Disease

4.3. Etiology

4.4. Signs and Symptoms

4.5. Clinical Presentation

4.6. Histopathology

4.7. Pathogenesis

4.8. Prognosis

4.9. Risk Factors

4.10. Diagnosis

4.10.1. Differential Diagnosis

5. Epidemiology and Patient Population

5.1. Key Findings

6. 7MM Epidemiology

6.1. Assumptions and rationale

6.2. Diagnosed Moderate to Severe Cases of Alcoholic Hepatitis (AH) in 7MM

6.3. United States

6.3.1. Total Prevalent cases of Alcoholic Hepatitis (AH) in the United States

6.3.2. Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in the United States

6.3.3. Gender-specific cases of Alcoholic Hepatitis (AH) in the United States

6.3.4. Severity-specific cases of Alcoholic Hepatitis (AH) in the United States

6.4. Germany

6.4.1. Total Prevalent cases of Alcoholic Hepatitis (AH) in Germany

6.4.2. Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in Germany

6.4.3. Gender-specific cases of Alcoholic Hepatitis (AH) in Germany

6.4.4. Severity-specific cases of Alcoholic Hepatitis (AH) in Germany

6.5. France

6.5.1. Total Prevalent cases of Alcoholic Hepatitis (AH) in France

6.5.2. Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in France

6.5.3. Gender-specific cases of Alcoholic Hepatitis (AH) in France

6.5.4. Severity-specific cases of Alcoholic Hepatitis (AH) in France

6.6. Italy

6.6.1. Total Prevalent cases of Alcoholic Hepatitis (AH) in Italy

6.6.2. Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in Italy

6.6.3. Gender-specific cases of Alcoholic Hepatitis (AH) in Italy

6.6.4. Severity-specific cases of Alcoholic Hepatitis (AH) in Italy

6.7. Spain

6.7.1. Total Prevalent cases of Alcoholic Hepatitis (AH) in Spain

6.7.2. Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in Spain

6.7.3. Gender-specific cases of Alcoholic Hepatitis (AH) in Spain

6.7.4. Severity-specific cases of Alcoholic Hepatitis (AH) in Spain

6.8. United Kingdom

6.8.1. Total Prevalent cases of Alcoholic Hepatitis (AH) in the United Kingdom

6.8.2. Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in the United Kingdom

6.8.3. Gender-specific cases of Alcoholic Hepatitis (AH) in the United Kingdom

6.8.4. Severity-specific cases of Alcoholic Hepatitis (AH) in the United Kingdom

6.9. Japan

6.9.1. Total Prevalent cases of Alcoholic Hepatitis (AH) in Japan

6.9.2. Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in Japan

6.9.3. Gender-specific cases of Alcoholic Hepatitis (AH) in Japan

6.9.4. Severity-specific cases of Alcoholic Hepatitis (AH) in Japan

7. Treatment of Alcoholic Hepatitis

7.1. Treatment Guidelines

8. Unmet Needs

9. Organizations contributing toward AH

10. Case studies

10.1. Alcoholic hepatitis – the case for intensive management

10.2. Case of severe alcoholic hepatitis treated with granulocytapheresis

10.3. Severe Alcoholic Hepatitis: Atypical Presentation with Markedly Elevated Alkaline Phosphatase

10.4. Alcoholic Hepatitis with an Unexpected Histology: A Case Report

11. KOL Views

12. Appendix

12.1. Report Methodology

12.2. References

13. DelveInsight Capabilities

14. Disclaimer

15. About DelveInsight

List of Tables

Table 1: Alcoholic Hepatitis Signs and Symptoms

Table 2: Common signs and symptoms amongst hospitalized patients with alcoholic hepatitis

Table 3: Diagnosed Moderate to Severe Cases of Alcoholic Hepatitis (AH) in 7MM (2017–2030)

Table 4: Total Prevalent cases of Alcoholic Hepatitis (AH) in the United States (2017–2030)

Table 5: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in the US (2017–2030)

Table 6: Gender-specific cases of Alcoholic Hepatitis (AH) in the US (2017–2030)

Table 7: Severity-specific cases of Alcoholic Hepatitis (AH) in the US (2017–2030)

Table 8: Total Prevalent cases of Alcoholic Hepatitis (AH) in Germany (2017–2030)

Table 9: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in Germany (2017–2030)

Table 10: Gender-specific cases of Alcoholic Hepatitis (AH) in Germany (2017–2030)

Table 11: Severity-specific cases of Alcoholic Hepatitis (AH) in Germany (2017–2030)

Table 12: Total Prevalent cases of Alcoholic Hepatitis (AH) in France (2017–2030)

Table 13: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in France (2017–2030)

Table 14: Gender-specific cases of Alcoholic Hepatitis (AH) in France (2017–2030)

Table 15: Severity-specific cases of Alcoholic Hepatitis (AH) in France (2017–2030)

Table 16: Total Prevalent cases of Alcoholic Hepatitis (AH) in Italy (2017–2030)

Table 17: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in Italy (2017–2030)

Table 18: Gender-specific cases of Alcoholic Hepatitis (AH) in Italy (2017–2030)

Table 19: Severity-specific cases of Alcoholic Hepatitis (AH) in Italy (2017–2030)

Table 20: Total Prevalent cases of Alcoholic Hepatitis (AH) in Spain (2017–2030)

Table 21: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in the US (2017–2030)

Table 22: Gender-specific cases of Alcoholic Hepatitis (AH) in Spain (2017–2030)

Table 23: Severity-specific cases of Alcoholic Hepatitis (AH) in Spain (2017–2030)

Table 24: Total Prevalent cases of Alcoholic Hepatitis (AH) in the United Kingdom (2017–2030)

Table 25: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in the UK (2017–2030)

Table 26: Gender-specific cases of Alcoholic Hepatitis (AH) in the UK (2017–2030)

Table 27: Severity-specific cases of Alcoholic Hepatitis (AH) in the UK (2017–2030)

Table 28: Total Prevalent cases of Alcoholic Hepatitis (AH) in Japan (2017–2030)

Table 29: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in Japan (2017–2030)

Table 30: Gender-specific cases of Alcoholic Hepatitis (AH) in Japan (2017–2030)

Table 31: Severity-specific cases of Alcoholic Hepatitis (AH) in Japan (2017–2030)

Table 32: Current recommendations for the diagnosis and treatment of acute alcoholic hepatitis (AH)

List of Figures

Figure 1: Spectrum of alcoholic liver disease.

Figure 2: Histopathology of alcoholic hepatitis

Figure 3: Pathophysiology of Alcohol-Induced Liver Injury

Figure 4: Mechanisms of alcoholic liver disease

Figure 5: Pathogenesis of alcoholic hepatitis

Figure 6: Diagnosed Moderate to Severe Cases of Alcoholic Hepatitis (AH) in 7MM (2017–2030)

Figure 7: Total Prevalent Cases of AH in the United States (2017–2030)

Figure 8: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in the US (2017–2030)

Figure 9: Gender-specific cases of Alcoholic Hepatitis (AH) in the US (2017–2030)

Figure 10: Severity-specific cases of Alcoholic Hepatitis (AH) in the US (2017–2030)

Figure 11: Total Prevalent cases of Alcoholic Hepatitis (AH) in Germany (2017–2030)

Figure 12: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in Germany (2017–2030)

Figure 13: Gender-specific cases of Alcoholic Hepatitis (AH) in Germany (2017–2030)

Figure 14: Severity-specific cases of Alcoholic Hepatitis (AH) in Germany (2017–2030)

Figure 15: Total Prevalent cases of Alcoholic Hepatitis (AH) in France (2017–2030)

Figure 16: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in France (2017–2030)

Figure 17: Gender-specific cases of Alcoholic Hepatitis (AH) in France (2017–2030)

Figure 18: Severity-specific cases of Alcoholic Hepatitis (AH) in France (2017–2030)

Figure 19: Total Prevalent cases of Alcoholic Hepatitis (AH) in Italy (2017–2030)

Figure 20: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in Italy (2017–2030)

Figure 21: Gender-specific cases of Alcoholic Hepatitis (AH) in Italy (2017–2030)

Figure 22: Severity-specific cases of Alcoholic Hepatitis (AH) in Italy (2017–2030)

Figure 23: Total Prevalent cases of Alcoholic Hepatitis (AH) in Spain (2017–2030)

Figure 24: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in Spain (2017–2030)

Figure 25: Gender-specific cases of Alcoholic Hepatitis (AH) in Spain (2017–2030)

Figure 26: Severity-specific cases of Alcoholic Hepatitis (AH) in Spain (2017–2030)

Figure 27: Total Prevalent cases of Alcoholic Hepatitis (AH) in the UK (2017–2030)

Figure 28: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in the UK (2017–2030)

Figure 29: Gender-specific cases of Alcoholic Hepatitis (AH) in the UK (2017–2030)

Figure 30: Severity-specific cases of Alcoholic Hepatitis (AH) in the UK (2017–2030)

Figure 31: Total Prevalent cases of Alcoholic Hepatitis (AH) in Japan (2017–2030)

Figure 32: Diagnosed Prevalent cases of Alcoholic Hepatitis (AH) in Japan (2017–2030)

Figure 33: Gender-specific cases of Alcoholic Hepatitis (AH) in Japan (2017–2030)

Figure 34: Severity-specific cases of Alcoholic Hepatitis (AH) in Japan (2017–2030)

Figure 35: Proposed algorithm for management of patients with alcoholic hepatitis

Figure 36: Unmet Needs

  • Tags:
  • Alcoholic Hepatitis Epidemiology
  • Alcoholic Hepatitis
  • Alcoholic Hepatitis Pipeline
  • Alcoholic Hepatitis Companies
  • Alcoholic Hepatitis prevalent popu...
  • Alcoholic Hepatitis incident popul...
  • Alcoholic Hepatitis patients diagn...
  • Alcoholic Hepatitis treatment algo...

Forward to Friend

Need A Quote